Company Filing History:
Years Active: 2016
Title: Mike Robarge: Innovator in Pharmaceutical Compounds
Introduction
Mike Robarge is an accomplished inventor based in Burton, Ohio. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on serotonin receptor ligands. His research focuses on developing compounds that can be used as therapeutic agents for various medical conditions.
Latest Patents
Mike Robarge holds 1 patent related to a series of benzazepine compounds. These compounds are designed to modulate the activity of serotonin receptors (5-HT), which is crucial for treating diseases such as addiction, anxiety, depression, and obesity. His patent outlines the pharmaceutical compositions containing these compounds and their potential therapeutic applications.
Career Highlights
Throughout his career, Mike has been associated with Abt Holding Company, where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to advancements in the treatment of various disorders, showcasing his commitment to improving healthcare outcomes.
Collaborations
Mike Robarge has collaborated with notable colleagues, including John Joseph Harrington and David Gerrish. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Mike Robarge is a dedicated inventor whose work in developing serotonin receptor ligands has the potential to impact the treatment of several medical conditions. His contributions to the field of pharmaceuticals reflect his commitment to innovation and improving patient care.